Evidence map›Paper›PMID 35292413›Full record

ReviewActa biomaterialia2022

Biomaterials for recruiting and activating endogenous stem cells in situ tissue regeneration.

Ingrid Safina, Mildred C Embree

Abstract readReview
In one paragraph

Review in Acta biomaterialia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Nanoparticle-integrated smart hydrogel with HJournal of nanobiotechnology · 2026
    Article
  5. CRISPR-Based Therapy for Ischemic Stroke: A Narrative Review.Cellular and molecular neurobiology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Advanced small extracellular vesicles delivery systems forExtracellular vesicles and circulating nucleic acids · 2026
    Review
  11. Review
  12. Dynamic Fibrous Hydrogels for Stem Cell Homing and In Situ Bone Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ingrid SafinaCartilage Biology and Regenerative Medicine Laboratory, College of Dental Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Mildred C EmbreeCartilage Biology and Regenerative Medicine Laboratory, College of Dental Medicine, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: mce2123@cumc.columbia.edu.

Funding

Improvement of Animal Models for TMJ Stem Cell-Based RegenerationR01DE029068 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI EMBREE, MILDRED CHRISTINE · 2019 to 2023
$3.6M
Development of Drug Delivery Technology for Stem Cell Based TMJ RegenerationR42DE028215 · NIDCR · WNT SCIENTIFIC, LLC · PI CHEN, MO, EMBREE, MILDRED CHRISTINE · 2020 to 2021
$1.5M
NIDCR NIH HHS R01 DE029068NIDCR NIH HHS R42 DE028215
6 · The paper itself

Abstract

Over the past two decades in situ tissue engineering has emerged as a new approach where biomaterials are used to harness the body's own stem/progenitor cells to regenerate diseased or injured tissue. Immunomodulatory biomaterials are designed to promote a regenerative environment, recruit resident stem cells to diseased or injured tissue sites, and direct them towards tissue regeneration. This review explores advances gathered from in vitro and in vivo studies on in situ tissue regenerative therapies. Here we also examine the different ways this approach has been incorporated into biomaterial sciences in order to create customized biomaterial products for therapeutic applications in a broad spectrum of tissues and diseases. STATEMENT OF SIGNIFICANCE: Biomaterials can be designed to recruit stem cells and coordinate their behavior and function towards the restoration or replacement of damaged or diseased tissues in a process known as in situ tissue regeneration. Advanced biomaterial constructs with precise structure, composition, mechanical, and physical properties can be transplanted to tissue site and exploit local stem cells and their micro-environment to promote tissue regeneration. In the absence of cells, we explore the critical immunomodulatory, chemical and physical properties to consider in material design and choice. The application of biomaterials for in situ tissue regeneration has the potential to address a broad range of injuries and diseases.

Indexed as

Biocompatible MaterialsTissue EngineeringStem CellsWound HealingBiocompatible MaterialsImmunomodulatory biomaterialsIn situ tissue engineeringMacrophage polarizationStem cell fate controlStem cell recruitment

Identifiers

PMID35292413
PMCPMC9035107

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.